Drug intelligence / Profile preview

Cibalax Kids

Development stage: Unknown
Lead developer: Ceres Pharma
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Cibalax Kids is a pediatric dietary supplement developed by the Belgian company Vesale Pharma, designed to support digestive health and manage constipation in children from the age of 3. The product is a synbiotic combination containing 2 billion CFU of the probiotic strain *Bifidobacterium lactis* Bb-12, prebiotic fructo-oligosaccharides (Actilight® FOS), and psyllium fiber (*Plantago ovata*). It utilizes Vesale Pharma's proprietary Intelicaps® microencapsulation technology, which protects the lyophilized bacteria to ensure high survival rates through the gastric environment. Administered orally via sachets, Cibalax Kids works by increasing fecal bulk and modulating the gut microbiota to naturally promote regular intestinal transit and alleviate occasional or chronic constipation.

Brand names: Cibalax Kids

Beyond the preview

Go deeper on Cibalax Kids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cibalax Kids.

Explore the full profile